Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mullin TM"'
Publikováno v:
Clinical Pharmacology & Therapeutics; Dec2016, Vol. 100 Issue 6, p626-632, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kirkner A; Rape, Abuse & Incest National Network (RAINN), United States of America. Electronic address: annek@rainn.org., Goodman KL; Rape, Abuse & Incest National Network (RAINN), United States of America. Electronic address: kimberlyg@rainn.org., Mullin TM; Rape, Abuse & Incest National Network (RAINN), United States of America. Electronic address: taram@rainn.org., Wright AW; Virginia Commonwealth University, United States of America. Electronic address: anna.wright@vcuhealth.org.
Publikováno v:
Child abuse & neglect [Child Abuse Negl] 2024 Mar; Vol. 149, pp. 106658. Date of Electronic Publication: 2024 Feb 09.
Autor:
Kamke K; Research & Evaluation Team, Department of Victim Services, Rape, Abuse & Incest National Network (RAINN), Washington, D.C.. Electronic address: kristynk@rainn.org., Mullin TM; Research & Evaluation Team, Department of Victim Services, Rape, Abuse & Incest National Network (RAINN), Washington, D.C., Goodman KL; Research & Evaluation Team, Department of Victim Services, Rape, Abuse & Incest National Network (RAINN), Washington, D.C.
Publikováno v:
The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2023 Dec; Vol. 73 (6), pp. 1077-1082. Date of Electronic Publication: 2023 Sep 09.
Autor:
Goodman KL; Rape, Abuse, and Incest National Network, Washington, DC, United States., Kamke K; Rape, Abuse, and Incest National Network, Washington, DC, United States., Mullin TM; Rape, Abuse, and Incest National Network, Washington, DC, United States.
Publikováno v:
JMIR public health and surveillance [JMIR Public Health Surveill] 2023 Aug 11; Vol. 9, pp. e44760. Date of Electronic Publication: 2023 Aug 11.
Autor:
Elliott SA; Rape, Abuse & Incest National Network, Research and Evaluation, Washington DC, USA., Bardwell ES; Rape, Abuse & Incest National Network, Research and Evaluation, Washington DC, USA., Kamke K; Rape, Abuse & Incest National Network, Research and Evaluation, Washington DC, USA., Mullin TM; Rape, Abuse & Incest National Network, Research and Evaluation, Washington DC, USA., Goodman KL; Rape, Abuse & Incest National Network, Research and Evaluation, Washington DC, USA.
Publikováno v:
Journal of interpersonal violence [J Interpers Violence] 2023 Jan; Vol. 38 (1-2), pp. NP84-NP107. Date of Electronic Publication: 2022 Mar 26.
Autor:
Willis JR; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Berndsen ZT; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Ma KM; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Steichen JM; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Schiffner T; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Landais E; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Liguori A; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Kalyuzhniy O; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Allen JD; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Baboo S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Omorodion O; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Diedrich JK; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Hu X; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Georgeson E; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Phelps N; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Eskandarzadeh S; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Groschel B; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Kubitz M; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Adachi Y; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Mullin TM; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Alavi NB; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA., Falcone S; Moderna Inc., Cambridge, MA 02139, USA., Himansu S; Moderna Inc., Cambridge, MA 02139, USA., Carfi A; Moderna Inc., Cambridge, MA 02139, USA., Wilson IA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Yates JR 3rd; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Paulson JC; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Crispin M; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Ward AB; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Schief WR; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: schief@scripps.edu.
Publikováno v:
Immunity [Immunity] 2022 Nov 08; Vol. 55 (11), pp. 2149-2167.e9. Date of Electronic Publication: 2022 Sep 29.
Autor:
Elliott SA; Rape, Abuse & Incest National Network (RAINN), Research and Evaluation, 1220 L St NW, Washington, DC 20005, United States of America. Electronic address: shannone@rainn.org., Goodman KL; Rape, Abuse & Incest National Network (RAINN), Research and Evaluation, 1220 L St NW, Washington, DC 20005, United States of America. Electronic address: kimberlyg@rainn.org., Bardwell ES; Rape, Abuse & Incest National Network (RAINN), Research and Evaluation, 1220 L St NW, Washington, DC 20005, United States of America. Electronic address: emmab@rainn.org., Mullin TM; Rape, Abuse & Incest National Network (RAINN), Research and Evaluation, 1220 L St NW, Washington, DC 20005, United States of America. Electronic address: taram@rainn.org.
Publikováno v:
Child abuse & neglect [Child Abuse Negl] 2022 May; Vol. 127, pp. 105567. Date of Electronic Publication: 2022 Mar 09.
Autor:
Sheriff DD; Department of Integrative Physiology, The University of Iowa, 424 Field House, Iowa City, IA 52242, USA. don-sheriff@uiowa.edu, Mullin TM, Wong BJ, Ladouceur M
Publikováno v:
Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2009 Mar; Vol. 195 (3), pp. 367-74. Date of Electronic Publication: 2008 Oct 10.